01172018Headline:

Archives

Home

Emily Beeson

Plaintiffs win big in Xarelto lawsuit

A Pennsylvania state court has returned a verdict in favor of a person injured by the blood thinner Xarelto in the amount of almost $28 million. The verdict comes on the heels of the third defense verdict in the consolidated […]

Roopal Luhana

AndroGel and Axiron Trials Scheduled for January

In June 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally-filed testosterone replacement lawsuits into one court in the Northern District of Illinois. District Court Judge Matthew Kennelly is overseeing the pre-trial proceedings. The lawsuits before Judge […]

Roopal Luhana

Indiana Couple Wins First Xarelto Trial in Philadelphia ($27.8M)

On December 5, 2017, an Indiana couple won their Xarelto lawsuit in Philadelphia. The jury ordered that the drug manufacturers, Bayer AG and Johnson & Johnson (J&J), pay $27.8 million for failing to warn about the blood-thinner’s serious side effects. […]

Derek T. Braslow

Nuedexta: Did Greed Push this Pill’s Popularity?

Avanir Pharmaceuticals manufactures Nuedexta, a prescription drug medication approved by the Food and Drug Administration (FDA) to treat a rare condition—pseudobulbar affect (PBA)—where sufferers experience uncontrollable laughing and crying. Yet, a recent CNN investigation has found that doctors increasingly are […]

Eric Washburn

Dangerous Drugs and the Injuries Victims Suffer

Despite the required testing and approval process put in place by the Food and Drug Administration (FDA), dangerous drugs still end up on the market and drug recalls take place. Even though clinical trials are supposed to find any safety […]

Eric T. Chaffin

Plaintiffs Seek Consolidation of Onglyza Lawsuits

Back in July 2009, the FDA approved the new drug Onglyza (saxagliptin) for the treatment of type 2 diabetes. In 2014, however, they issued a drug safety communication stating that they had requested additional clinical trial data from the manufacturers, […]

Brett Emison

Trial Court: Bair Hugger Warming Blanket Lawsuits Will Proceed to Trial

In a critical victory for victims of Bair Hugger warming blanket infections, the trial judge presiding over thousands of hip and knee joint infection lawsuits ruled this week that the claims will continue against 3M over its Bair Hugger forced […]

Kendra Goldhirsch

Studies Say No Difference in Safety Between Xarelto and Warfarin

In a new study published by the British Medical Journal (BMJ), researchers reported that so-called “new-generation” blood thinners like Xarelto and Eliquis were no safer when it came to the risk of excessive bleeding than warfarin, the leading blood thinner […]

Eric T. Chaffin

City Attorney Opens Investigation Into Potential Unethical Use of Nuedexta

On October 19, 2017, “KTLA” news announced that Los Angeles City Attorney Mike Feuer had opened an investigation into Avanir Pharmaceuticals—headquartered in California—and their marketing of their drug “Nuedexta” to nursing homes. Nuedexta is an FDA-approved drug which treats a […]

Kendra Goldhirsch

Georgia Man Blames Onglyza for Heart Failure

On October 25, 2017, a Georgia man filed a new Onglyza lawsuit against manufacturers Bristol-Myers Squibb and AstraZeneca Pharmaceuticals, in the U.S. District Court for the Middle District of Georgia. He claims that after taking Onglyza, which is a type […]